Stage 2 3 and 4 P*
Number of eyes 15 20 and 2  
Shortening of disc-to-fovea distance, μm 107.8 ± 107.8 136.7 ± 134.9 0.012
Preoperative mean BCVA,logMAR units 0.43 ± 0.24 0.47 ± 0.23 0.61
Postoperative mean BCVA,logMAR units -0.098 ± 0.23 0.027 ± 0.17 0.17
Macular hole size, μm 402 ± 164.1 385.5 ± 125.5 0.74
Basal macular hole size, μm 539.9 ± 212.2 674.1 ± 266.6 0.098
Staining(TA /ICG/ BBG) 10 / 4 / 1 12 / 7 / 3  
Area of ILM peeling (DA) 3.8 ± 2.3 3.9 ± 2.3 0.91
Data are expressed as the means ±standard deviation * Unpaired t tests TA: Triamcinolone Acetonide;ICG: Indocyanine Green; BBG:Brilliant Blue G; DA: Approximate Disc Area
Table 2: Comparison of OCT measurements and demographic features of Stage 2 and 3/4.